{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:19:03Z","timestamp":1785842343794,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ygyno.2006.01.007","type":"journal-article","created":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T07:25:10Z","timestamp":1140593110000},"page":"480-488","source":"Crossref","is-referenced-by-count":71,"title":["Surgical resection of recurrent endometrial carcinoma"],"prefix":"10.1016","volume":"102","author":[{"given":"Christopher S.","family":"Awtrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G.","family":"Cadungog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaled M.","family":"Alektiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Hummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2006.01.007_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2006.01.007_bib2","first-page":"45","article-title":"Carcinoma of the corpus uteri","volume":"6","author":"Creasman","year":"2001","journal-title":"J. Epidemiol. Biostat."},{"key":"10.1016\/j.ygyno.2006.01.007_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0090-8258(84)90063-5","article-title":"Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients","volume":"17","author":"Aalders","year":"1984","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib4","first-page":"96","article-title":"Treatment failure in endometrial carcinoma","volume":"75","author":"Burke","year":"1990","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib5","article-title":"Carcinoma of the corpus uteri","volume":"vol. 23","author":"Creasman","year":"1998"},{"key":"10.1016\/j.ygyno.2006.01.007_bib6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/gyno.1995.0012","article-title":"Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme","volume":"59","author":"Reddoch","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib7","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/1097-0142(197905)43:5<1944::AID-CNCR2820430555>3.0.CO;2-Y","article-title":"Endometrial carcinoma: causes of death and sites of treatment failure","volume":"43","author":"Yoonessi","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.01.007_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/gyno.2000.5727","article-title":"Results of radical radiotherapy for recurrent endometrial cancer","volume":"77","author":"Wylie","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0360-3016(00)00642-8","article-title":"Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy","volume":"48","author":"Jereczek-Fossa","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2006.01.007_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/gyno.1996.0040","article-title":"Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration","volume":"60","author":"Morris","year":"1996","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1006\/gyno.1999.5536","article-title":"Pelvic exenteration for recurrent endometrial cancer","volume":"75","author":"Barakat","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/gyno.1998.5017","article-title":"Maximal cytoreductive surgery as a reasonable therapeutic alternative for recurrent endometrial cancer","volume":"70","author":"Scarabelli","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/cncr.11868","article-title":"Surgical treatment of recurrent endometrial carcinoma","volume":"100","author":"Campagnutta","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.01.007_bib14","first-page":"13","article-title":"Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III):Gynecologic Oncology Group Study No 122","volume":"19","author":"Randall","year":"1995","journal-title":"Monogr. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2006.01.007_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/01.sla.0000133124.62619.1f","article-title":"Measuring morbidity","volume":"240","author":"Jaques","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2006.01.007_bib16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00000658-200206000-00007","article-title":"Quality of complication reporting in the surgical literature","volume":"235","author":"Martin","year":"2002","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ygyno.2006.01.007_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ygyno.2003.11.008","article-title":"Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study","volume":"92","author":"Fiorica","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib18","series-title":"Principles and practice of gynecologic oncology","first-page":"823","article-title":"Corpus: epithelial tumors","author":"Trope","year":"2004"},{"key":"10.1016\/j.ygyno.2006.01.007_bib19","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2004.07.184","article-title":"Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filfrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study","volume":"22","author":"Fleming","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/gyno.1997.4838","article-title":"The role of surgical cytoreduction in stage IV endometrial carcinoma","volume":"67","author":"Chi","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ygyno.2004.03.015","article-title":"Optimal surgical cytoreduction in patients with stage III and stage IV endometrial carcinoma: a study of morbidity and survival","volume":"93","author":"Lambrou","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/gyno.2000.5843","article-title":"Stage IV endometrial carcinoma. The role of surgical cytoreductive surgery and determinants of survival","volume":"78","author":"Bristow","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1525-1438.2002.t01-1-01133.x","article-title":"The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer","volume":"12","author":"Ayhan","year":"2002","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2006.01.007_bib24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1525-1438.2003.13385.x","article-title":"FIGO stage IIIc endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival","volume":"13","author":"Bristow","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2006.01.007_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2004.07.033","article-title":"Tertiary cytoreduction in patients with recurrent ovarian carcinoma","volume":"95","author":"Leitao","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib26","first-page":"146","article-title":"Variables associated with postoperative deep venous thrombosis: a prospective study of 411 gynecology patients and creation of a prognostic model","volume":"69","author":"Clarke-Pearson","year":"1987","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/gyno.1994.1307","article-title":"Prognostic indicators of survival in advanced endometrial cancer","volume":"55","author":"Behbakht","year":"1994","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.007_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X","article-title":"The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma","volume":"88","author":"Eisenkop","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.01.007_bib29","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/1097-0142(19921015)70:8<2129::AID-CNCR2820700820>3.0.CO;2-U","article-title":"Radical surgical procedure improves survival time in patients with recurrent ovarian cancer","volume":"70","author":"Janicke","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.01.007_bib30","article-title":"Identification of prognostic factors for survival following secondary cytoreductive surgery in patients with recurrent epithelial ovarian carcinoma [Abstract]","author":"Chi","year":"2003"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T04:25:39Z","timestamp":1547785539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0090825806000345"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.01.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}